-
2025-524229-41-00
5
Triple negative breast cancer
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2024-514850-59-00
5
2025-02-24
Appendicitis
-
2024-512571-12-00
6
2024-11-29
Infertility
-
2023-509706-30-00
5
2024-10-18
Heart failure (HF)
-
2023-506115-17-00
5
2024-10-14
Metastatic Colorectal Cancer
-
2024-516195-15-00
5
2024-09-10
Advanced NSCLC
-
2023-507763-18-01
6
2024-05-21
Placenta previa, preterm birth
-
2023-508586-33-00
5
2024-05-14
multiple myeloma
-
2023-506792-94-00
11
2024-03-04
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
-
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
-
2022-502781-24-01
5
2024-06-05
ASCVD - Atherosclerotic Cardiovascular Disease
-
2022-502664-21-00
6
2023-05-01
multiple sclerosis
-
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2024-516205-23-00
4
2019-04-09
Breast cancer
-
2024-516204-42-00
5
2017-11-21
Breast cancer
-
2024-514841-12-00
5
2015-10-27
To determine whether the addition of palbociclib to adjuvant endocrine
-
2024-511096-15-00
5
2014-08-01
Breast Cancer
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
-
2023-510557-42-00
4
2017-07-10
chronic lymphocytic leukemia
-
2024-516581-11-00
5
Advanced stage NSCLC